Board changes
12 November 2026

Porvair plc
("Porvair" or the "Group" or the "Company")
Board changes
Porvair plc, the specialist filtration, laboratory and environmental technology group, announces the following Board changes:
Dr Ros Rivaz
Dr Ros Rivaz has been appointed as Senior Independent Non-Executive Director of the Company and Chair of the Remuneration Committee with immediate effect. Ros will also join the Audit Committee and Nomination Committee.
Ros brings extensive international leadership experience in executive and non-executive roles across manufacturing and engineering. She is currently Chair of Companies House, Senior Independent Director of Victrex plc, a UK FTSE 250 company, and Lead Independent Director of Aperam S.A, listed in Amsterdam, Brussels, Paris, Madrid and Luxembourg. Ros was previously Chair of Anglian Water Services and the Nuclear Decommissioning Authority, and has held board roles at numerous other companies including Computacenter plc, and Convatec Group plc. She was also previously Chief Operating Officer of Smith & Nephew plc and held senior management positions at ExxonMobil, Diageo, ICI and Tate & Lyle.
Porvair confirms that there are no further matters in relation to Dr Ros Rivaz’s appointment to be disclosed pursuant to the requirements of paragraph 6.4.8 of the Listing Rules of the UK Listing Authority.
Sheena Mackay
Sheena Mackay has stepped down from the Board with immediate effect to take up a role at another company. The Board thanks Sheena for her contribution to Porvair and wishes her well for the future.
Laura Wand
Laura Wand, a Non-Executive Director of the Company, has been appointed as the director responsible for employee engagement with immediate effect.
For further information, please contact:
|
Porvair plc |
+44 (0)1553 765 500 | |
|
Hooman Caman Javvi, Chief Executive Officer Andrew Douglass, Group Company Secretary |
| |
|
Alma Strategic Communications |
+44 (0)20 3405 0205 | |
|
Andrew Jaques / Josh Royston / Hannah Campbell / Rose Docherty |
| |
Notes to editors
Porvair is a decentralised portfolio of specialist filtration, laboratory and environmental technology businesses, providing technically differentiated, mission-critical solutions with defensible positions across diverse end markets. The Group is organised across three divisions: Aerospace & Industrial; Laboratory; and Metal Melt Quality.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.
Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.
In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.
The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
FOR OUR FULL DISCLAIMER CLICK HERE